These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6506985)

  • 1. [Relation between the effect of tranquilizers and various features of personality structure among patients with borderline states].
    Aleksandrovskiĭ IuA; Khrulenko-Varnitskiĭ IO; Uvarova LG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1367-76. PubMed ID: 6506985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relation between the dynamics of EEG indices after a single dose of the tranquilizer phenazepam and its efficacy during a course of treatment of patients with borderline neuropsychological disorders].
    Uvarova LG; Titaeva MA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(11):1701-9. PubMed ID: 4082841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinico-pharmacologic analysis neurovegetotropic activity of tranquilizers].
    Aleksandrovskiĭ IuA; Ben'kovich BI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(5):743-50. PubMed ID: 6464592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of tranquilizers on short-term memory in patients with borderline forms of neuropsychiatric disorders].
    Maksimenko TV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(5):737-40. PubMed ID: 6880505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinico-pharmacological characteristics of combined administration of tranquilizing agents and other psychotropic drugs].
    Aleksandrovskiĭ IuA; Neznamov GG; Tarnavskiĭ IuB; Valueva LN; Sigunova EA
    Farmakol Toksikol; 1982; 45(3):36-41. PubMed ID: 7095127
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinicobiochemical parallels in borderline neuropsychic disorders].
    Ushakov GK; Maslova AF; Kostiunina ZG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(11):1663-6. PubMed ID: 6119860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The positive effect of alprazolam in the treatment of three patients with borderline personality disorder.
    Faltus FJ
    Am J Psychiatry; 1984 Jun; 141(6):802-3. PubMed ID: 6145360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of tranquilizers on the critical flicker fusion frequency in the visual analyzer].
    Ben'kovich BI; Marshak OV
    Fiziol Cheloveka; 1984; 10(6):999-1004. PubMed ID: 6151932
    [No Abstract]   [Full Text] [Related]  

  • 9. [The therapeutic efficacy and the effect of gidazepam and fenazepam on the psychophysiological status and on the performance of operators with mental disorders at a neurotic level].
    Neznamov GG; Morozov IS; Barchukov VG; Teleshova ES; Siuniakov SA; Zhirov EN; Tkachev AE; Belyĭ IuN; Kolotilinskaia NV; Safarova TP; Barannikov AS; Chernyĭ AV; Shestopalov SS
    Eksp Klin Farmakol; 1997; 60(4):17-21. PubMed ID: 9376749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinico-dynamic analysis of the borderline states of advanced age].
    Semke VIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1369-74. PubMed ID: 3425081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alprazolam-induced dyscontrol in borderline personality disorder.
    Gardner DL; Cowdry RW
    Am J Psychiatry; 1985 Jan; 142(1):98-100. PubMed ID: 2857071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of psychophysiologic indices for the prognosis of the clinical action of tranquilizers].
    Aleksandrovskiĭ IuA; Ben'kovich BI; Marshak OV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(12):90-8. PubMed ID: 2907706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The psychopharmacology of borderline personality disorders.
    Montgomery SA
    Acta Psychiatr Belg; 1987; 87(3):260-6. PubMed ID: 3673629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The correlation of the electroencephalographic and clinical effects of benzodiazepine tranquilizers in patients with mental disorders at the neurotic level].
    Bochkarev VK; Neznamov GG
    Eksp Klin Farmakol; 1995; 58(4):18-22. PubMed ID: 7580745
    [No Abstract]   [Full Text] [Related]  

  • 15. Benzodiazepines in the treatment of depressive, borderline personality, and schizophrenic disorders.
    Schatzberg AF; Cole JO
    Br J Clin Pharmacol; 1981; 11 Suppl 1(Suppl 1):17S-22S. PubMed ID: 6133529
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological treatment for borderline personality disorder.
    Berger PA
    Bull Menninger Clin; 1987 May; 51(3):277-84. PubMed ID: 3580662
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of tranquilizers on borderline and schizotypal patients questioned.
    Rockland LH
    Am J Psychiatry; 1985 May; 142(5):665-6. PubMed ID: 3885764
    [No Abstract]   [Full Text] [Related]  

  • 18. [Phenazepam in the treatment of borderline forms of neuropsychiatric disorders].
    Kalandarishvili AS; Bortnik TL; Berdina ES; Lesovskaia TV; Aleksandrovskiĭ IuA
    Sov Med; 1979 Jul; (7):8-14. PubMed ID: 41325
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacotherapy of the borderline patient: a critical review and clinical guidelines.
    Kutcher SP; Blackwood DH
    Can J Psychiatry; 1989 May; 34(4):347-53. PubMed ID: 2567621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of psychopharmacotherapy in the treatment of borderline personality disorder].
    Leitner P; Serfling R
    Psychiatr Prax; 1993 Nov; 20(6):207-10. PubMed ID: 7906044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.